LEXICON PHARMACEUTICALS INC's ticker is LXRX and the CUSIP is 528872302. A total of 107 filers reported holding LEXICON PHARMACEUTICALS INC in Q4 2022. The put-call ratio across all filers is 0.29 and the average weighting 0.1%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q3 2023 | $43,915 | -52.4% | 40,289 | 0.0% | 0.00% | – |
| Q2 2023 | $92,262 | -27.9% | 40,289 | -23.4% | 0.00% | – |
| Q1 2023 | $127,878 | +82.7% | 52,625 | +43.6% | 0.00% | – |
| Q4 2022 | $69,993 | -19.5% | 36,646 | +1.5% | 0.00% | – |
| Q3 2022 | $87,000 | +42.6% | 36,090 | +9.1% | 0.00% | – |
| Q2 2022 | $61,000 | -23.8% | 33,092 | -12.7% | 0.00% | – |
| Q1 2022 | $80,000 | -52.1% | 37,895 | -10.6% | 0.00% | – |
| Q4 2021 | $167,000 | -13.9% | 42,411 | +5.4% | 0.00% | – |
| Q3 2021 | $194,000 | -74.6% | 40,253 | -75.8% | 0.00% | – |
| Q2 2021 | $764,000 | +47.8% | 166,281 | +89.0% | 0.00% | – |
| Q1 2021 | $517,000 | -1.3% | 87,998 | -42.6% | 0.00% | – |
| Q4 2020 | $524,000 | -41.3% | 153,176 | -75.3% | 0.00% | -100.0% |
| Q3 2020 | $892,000 | +2130.0% | 619,330 | +2964.2% | 0.00% | – |
| Q2 2020 | $40,000 | +48.1% | 20,212 | +43.0% | 0.00% | – |
| Q1 2020 | $27,000 | -93.6% | 14,133 | -86.1% | 0.00% | – |
| Q4 2019 | $420,000 | +10.2% | 101,456 | -20.2% | 0.00% | – |
| Q3 2019 | $381,000 | -78.3% | 127,153 | -54.5% | 0.00% | -100.0% |
| Q2 2019 | $1,754,000 | +21.5% | 279,195 | +7.3% | 0.00% | 0.0% |
| Q1 2019 | $1,444,000 | -26.4% | 260,167 | -12.0% | 0.00% | 0.0% |
| Q4 2018 | $1,962,000 | -63.8% | 295,619 | -41.8% | 0.00% | -50.0% |
| Q3 2018 | $5,419,000 | -29.8% | 507,967 | -21.0% | 0.00% | 0.0% |
| Q2 2018 | $7,717,000 | +111.0% | 643,168 | +50.6% | 0.00% | 0.0% |
| Q1 2018 | $3,658,000 | -32.4% | 427,168 | -22.1% | 0.00% | -33.3% |
| Q4 2017 | $5,413,000 | +33.2% | 548,119 | +65.6% | 0.00% | 0.0% |
| Q3 2017 | $4,064,000 | -22.2% | 330,905 | +4.2% | 0.00% | -25.0% |
| Q2 2017 | $5,223,000 | +169.8% | 317,646 | +135.1% | 0.00% | +300.0% |
| Q1 2017 | $1,936,000 | +427.5% | 135,092 | +408.3% | 0.00% | – |
| Q4 2016 | $367,000 | -64.4% | 26,576 | -53.5% | 0.00% | -100.0% |
| Q3 2016 | $1,032,000 | +71.7% | 57,173 | +36.0% | 0.00% | – |
| Q2 2016 | $601,000 | +26.0% | 42,026 | +5.1% | 0.00% | – |
| Q1 2016 | $477,000 | +126.1% | 39,972 | +150.3% | 0.00% | – |
| Q4 2015 | $211,000 | -91.1% | 15,967 | -92.7% | 0.00% | -100.0% |
| Q3 2015 | $2,362,000 | +978.5% | 220,112 | +704.9% | 0.00% | – |
| Q2 2015 | $219,000 | – | 27,346 | – | 0.00% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| Ulys, L.L.C. | 4,321,214 | $25,366,000 | 100.00% |
| Artal Group S.A. | 71,178,364 | $417,817,000 | 7.38% |
| BVF INC/IL | 8,394,000 | $49,273,000 | 1.85% |
| Boothe Investment Group, Inc. | 435,939 | $2,559,000 | 1.49% |
| Campbell & CO Investment Adviser LLC | 103,100 | $605,000 | 0.37% |
| NEA Management Company, LLC | 2,382,286 | $13,984,000 | 0.31% |
| PINNACLE ASSOCIATES LTD | 2,167,172 | $12,721,000 | 0.24% |
| Eversept Partners, LP | 410,593 | $2,410,181 | 0.18% |
| UNIVERSITY OF TEXAS/TEXAS AM INVESTMENT MANAGEMENT CO | 35,714 | $210,000 | 0.12% |
| OCCUDO QUANTITATIVE STRATEGIES LP | 66,299 | $389,000 | 0.08% |